{
    "code": 0,
    "data": [
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "6f25d94a-3f62-4bee-b22d-27b8b9c61813",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33df2677-efab-49bb-8997-d75763fea5db.pdf",
            "news_date": "2026-02-09 19:19:33",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Financial Results for the quarter ended 31st December 2025",
            "news_id": "7c4dff17-ed7f-46dc-b3e3-f74dd82cf3cf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8bd25be-2c18-4596-8f76-0c57ce9f6355.pdf",
            "news_date": "2026-02-07 16:43:06",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the conference call held on 11th November 2025",
            "news_id": "f97e755e-5330-422b-8295-8f7a2afe7faf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6582f724-b884-472c-977c-36e0c128a7e1.pdf",
            "news_date": "2025-11-13 18:19:07",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analyst/ Investor Conference call pertaining to the financial results for the quarter ended 30th September 2025",
            "news_id": "fc0e4984-c956-42bf-8507-e11c943397fd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1c5d052-3285-415c-9573-759d87ba5611.pdf",
            "news_date": "2025-11-11 14:49:03",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for the second quarter and half year ended 30th September 2025",
            "news_id": "3f71b630-0227-4d4f-82b2-567d4c625771",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=faca478f-827d-419a-a4dc-966a097596e8.pdf",
            "news_date": "2025-11-10 18:13:07",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th September 2025",
            "news_body": "Financial results for the quarter ended 30th September 2025",
            "news_id": "1506c8e3-7346-4803-b670-4d7b2d97a0c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9791afef-81a7-4ff4-b97f-178b1a53a02e.pdf",
            "news_date": "2025-11-08 14:21:18",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter Ended June 30 2025",
            "news_body": "Financial Results for the quarter ended June 30 2025",
            "news_id": "490f9e1c-79f1-4406-a376-8050d64000e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11f9cec8-de8f-476f-852b-4915c6a17b75.pdf",
            "news_date": "2025-08-09 14:49:46",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earning call geld on 2nd June 2025.",
            "news_id": "2ccfddaa-56f7-42d0-9cc2-de9e1fbac1dc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=129447e4-b59e-4b8a-9ae0-32f6f11dbe3e.pdf",
            "news_date": "2025-06-05 12:11:39",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investor call.",
            "news_id": "63081601-c6b4-494d-859d-e6b08057acd8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=420e6f20-7358-4b39-a96b-e21b4d6ad2e6.pdf",
            "news_date": "2025-06-02 15:17:07",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Quarter and year ended 31st March 2025",
            "news_id": "c8bf3147-6e6e-44ab-ab44-57ac2da45af2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc7bf01c-239a-42c0-9f95-ae55500f8d5e.pdf",
            "news_date": "2025-05-31 19:09:06",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Fourth Quarter And Year Ended 31St March 2025",
            "news_body": "Approved financial Results for the fourth quarter and year ended 31st March 2025",
            "news_id": "62fabf2e-cdf2-4bef-a805-26c7787aceeb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21e80d68-0c28-464e-9fb0-5f7236d21a23.pdf",
            "news_date": "2025-05-30 18:06:37",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results",
            "news_id": "4acc6195-7f5d-439a-b454-c27fd1e7d6bc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff07bb3a-0302-42c6-813c-c5fb07f3c3c0.pdf",
            "news_date": "2025-02-12 20:43:36",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31.12.2024",
            "news_body": "Financial Results for the quarter ended 31.12.2024",
            "news_id": "f1011688-8d06-4d48-8a73-b46335fdf4a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d7edaa3-00d1-45cd-a7e8-72f5ef641830.pdf",
            "news_date": "2025-02-12 14:21:51",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning Call held on 13.11.2024",
            "news_id": "f798edfe-9438-43fa-b896-3b93f5185477",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34d31f75-6e30-4a17-918f-3880dec6466c.pdf",
            "news_date": "2024-11-15 19:07:54",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors Call",
            "news_id": "a1ec7d1a-af60-47fb-afca-8162df181ecb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e292ffb2-9fa6-45fc-95a8-e62c1445f74e.pdf",
            "news_date": "2024-11-13 17:32:45",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Financial Results for the period ended 30th September 2024",
            "news_id": "5bc738ba-3ed0-4391-b2eb-e591f97611b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63c531a9-aa8d-446a-bc42-6b8552f00df8.pdf",
            "news_date": "2024-11-12 12:34:05",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The  Quarter Ended 30/09/2024",
            "news_body": "Financial Results for the quarte ended 30/09/2024",
            "news_id": "9eb09b71-5f27-476b-b44a-0e0103e49471",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e291bfcc-5a29-4e43-b1ae-e972ca9c3682.pdf",
            "news_date": "2024-11-08 18:57:44",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of conference call on 07th August, 2024",
            "news_id": "781466f3-7d4e-4e0a-9b4e-80e3707cabb9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=669f09d7-dcc3-402e-b261-05f50641e11b.pdf",
            "news_date": "2024-08-12 18:03:33",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the quarter ended 30th June, 2024",
            "news_id": "9dcfd6d4-7e8f-443c-8c38-296e8172486b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89d935ea-b0bf-4b20-be9a-bfe974a3e032.pdf",
            "news_date": "2024-08-07 15:17:48",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation of the Company for the quarter ended 30th June, 2024",
            "news_id": "21c01575-3a6b-4876-8519-04090b6e3e56",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08af0caa-a48d-4744-9bb5-380dfbe6e933.pdf",
            "news_date": "2024-08-06 17:58:03",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting And Financial Results.",
            "news_body": "Outcome of Board Meeting and Financial Results for the quarter ended 30th June, 2024.",
            "news_id": "3fdfebf6-f592-40e8-bda9-7ae2ab8f2d28",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b162293d-d868-4c14-b848-f04fb8b7780a.pdf",
            "news_date": "2024-08-05 15:23:51",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the fourth quarter and financial year ended 31st March, 2024",
            "news_id": "dc9976b6-b340-430a-89e4-def580f529a7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68f1b4d1-da23-4ffb-8e70-a248ff27d701.pdf",
            "news_date": "2024-05-31 15:52:24",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results",
            "news_id": "e49a6101-ec33-437f-a948-dae712bc5c20",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7af2fbfd-dd20-42c0-a96e-69ccbcf9fbad.pdf",
            "news_date": "2024-05-30 19:43:13",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Fourth Quarter And FY Ended 31St March, 2024",
            "news_body": "Financial Results for the Fourth quarter and FY ended 31st March, 2024",
            "news_id": "f1c06df7-ba9f-4379-b8c3-2c1b480d66e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61da9e9f-fdfb-460b-bf84-afefb98cb113.pdf",
            "news_date": "2024-05-29 13:33:39",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Investor call held on 12th February, 2024",
            "news_id": "ab0c66af-5a9a-4394-b20e-34e4e22ee484",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f1a3aa0-7109-426d-8f1f-fa5209effc0a.pdf",
            "news_date": "2024-02-12 19:10:56",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the third quarter ended 31st December, 2023",
            "news_id": "5ec57881-3137-4346-b661-d04a6c341d64",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77095d3c-3907-4eea-a9f8-2edece269e24.pdf",
            "news_date": "2024-02-10 16:23:57",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December, 2023",
            "news_body": "Financial Results for the quarter ended 31st December, 2023",
            "news_id": "94fd128d-4195-42b2-9a5e-bd2356bbff7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67718242-ce8f-47ad-a484-3432260dbf41.pdf",
            "news_date": "2024-02-08 19:04:26",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting - Approval Of Financial Results For The Quarter Ended 31St December, 2023 And Approval For Issue Of Share Warrants On Preferential Basis",
            "news_body": "Outcome of the Board Meeting - Approval of financial results for the quarter ended 31st December, 2023 and approval for issue of share warrants on preferential basis",
            "news_id": "ab47708e-59d4-48d0-b612-e114dec182c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35d96c0e-1d21-4374-a9df-5dcf9a82a51e.pdf",
            "news_date": "2024-02-08 19:01:06",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call",
            "news_id": "20714f2f-2b01-4e8c-b1d2-ea6bd2c6297f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6521349-1d68-4c59-bff0-7ca0aa1e0295.pdf",
            "news_date": "2023-11-10 17:28:52",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "bb0bdb73-5e0b-40de-a0d7-e58638e48d88",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18fd1da3-522e-4bdb-9576-f77f4719631c.pdf",
            "news_date": "2023-11-09 17:01:28",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome And Financial Results For The Quarter Ended 30Th September, 2023",
            "news_body": "Outcome and Financial Results for the quarter ended 30th September, 2023",
            "news_id": "07d68b9c-7596-4a77-900a-0810c1ec70a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f0c24fe-1d17-4ea9-9425-537ee679b8bf.pdf",
            "news_date": "2023-11-08 13:05:41",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Conference Call held on 10th August, 2023",
            "news_id": "1cb4a011-bd46-46df-a04a-8f9e325fc1c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c0ef820-a587-4428-99e0-205114cd388a.pdf",
            "news_date": "2023-08-17 17:22:48",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call",
            "news_id": "cd53c6a9-2310-46f3-828e-b99c71182002",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b48a5d1-9797-4e0a-9b83-50ad6eb5766d.pdf",
            "news_date": "2023-08-10 17:56:07",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results for the quarter ended 30.06.2023",
            "news_id": "40cff3a7-bd46-41bb-aeb9-8ae9244099fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a352d1a-84ef-4407-8780-cb3df7b10081.pdf",
            "news_date": "2023-08-09 18:50:13",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The First Quarter Ended 30Th June, 2023",
            "news_body": "Financial Results for the quarter ended 30th June, 2023",
            "news_id": "d3dae459-248f-4f31-9336-09bac4eccf00",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27eb689f-4fc9-4200-afa3-78a4c5a1fef4.pdf",
            "news_date": "2023-08-08 13:54:13",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call",
            "news_id": "c78b7046-37cb-421d-b1df-0a77925e2782",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e68a53eb-ee5b-4da1-a737-b0a008b74440.pdf",
            "news_date": "2023-05-26 17:32:04",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "81b6de7d-248f-49f0-984a-656e09e4f2de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3557221d-bd19-4e5a-b298-27753a154d97.pdf",
            "news_date": "2023-05-25 19:08:51",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Fourth Quarter And Year Ended 31.03.2023",
            "news_body": "Outcome of Board Meeting and Financial Results",
            "news_id": "78d65d84-599a-4402-af88-a6287981dad2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9d1bbf9-24b0-426c-9a05-bdf611a6b75d.pdf",
            "news_date": "2023-05-24 13:29:27",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting And Financial Results",
            "news_body": "Outcome of Board Meeting and Financial Results",
            "news_id": "59efe2b8-e8ec-4659-bf81-5edd304e5576",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=026787e0-4288-42d2-88e9-a84922b8d472.pdf",
            "news_date": "2023-05-24 13:23:35",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Conference Call held on 10th February, 2023.",
            "news_id": "06bd94aa-b887-4f13-9988-5d1818f4e731",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ac7f779-22ac-4d1a-86a7-911a4f8faff8.pdf",
            "news_date": "2023-02-14 18:59:53",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call",
            "news_id": "dae0f761-24be-4fdd-8c56-36bd9af5d38c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd24be50-6896-4408-9b9c-bdc8a8e44243.pdf",
            "news_date": "2023-02-10 15:32:24",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "d2c48a8d-e494-4462-8bfd-3f3590660712",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dcb9568-a17f-4d93-90d5-8dee9930c7e1.pdf",
            "news_date": "2023-02-09 18:52:53",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December, 2022",
            "news_body": "Financial Results for the quarter ended 31st December, 2022",
            "news_id": "50f0a62c-cfe1-436c-a540-5eec560db0ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee07994a-1435-446f-92e2-d170a025c574.pdf",
            "news_date": "2023-02-09 12:31:25",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting And Financial Results",
            "news_body": "Outcome of Board Meeting held on 09th February, 2023",
            "news_id": "798056f3-fbe0-4979-b3b0-99422a8d8862",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a093f38-3355-42aa-ae10-46f1cb9abaf7.pdf",
            "news_date": "2023-02-09 12:24:14",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2022",
            "news_body": "Disclosure of Related Party Transactions for the half year ended 30th September, 2022",
            "news_id": "bcdcfc64-7273-4156-a40b-4e5e2dfb2b04",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d289d16c-75cd-4196-b69a-825ba7f9139a.pdf",
            "news_date": "2022-11-22 17:21:02",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Analysts/Investors Conference Call",
            "news_id": "e95be7e1-a154-440a-8431-4d56d1e93224",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a6042ed-18da-448e-85c9-89be1e8c015f.pdf",
            "news_date": "2022-11-17 18:26:42",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "standalone and consolidated un-audited Financial Results for the quarter and half year ended 30th September, 2022",
            "news_id": "df60f33d-e8de-48f2-8ec8-5cfb25d829c4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97769382-4662-41c3-9c72-85fcb682f91e.pdf",
            "news_date": "2022-11-12 11:32:08",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 12-Nov-2022 To Consider Financial Statements For The Period Ended September 2022",
            "news_body": "outcome of the Board Meeting held on 12-Nov-2022 to consider financial statements for the period ended September 2022",
            "news_id": "abc8b1d8-a57e-47ab-a7de-8b09e468e40b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7453f09d-4a34-4c55-8472-d7341a8fbbb5.pdf",
            "news_date": "2022-11-12 11:27:15",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Auditor''s Limited Review Report For The Consolidated Financials Results For The Quarter Ended 30Th June 2022",
            "news_body": "We are herewith submitting Revised Auditor''s Limited Review Report for the Consolidated Financials Results against the quarter ended 30th June 2022",
            "news_id": "9ad54faf-f8fb-416a-9e8d-c1b51d4711fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fe9ed33-e083-436f-ac10-7d5cef01da80.pdf",
            "news_date": "2022-09-13 12:59:17",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of the Company for the first Quarter ended 30th June, 2022.",
            "news_id": "31fecd31-0142-46fe-81f0-6fb8c960bfdb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0827ec5-dc7a-4d68-9a3a-e1bb26809b4c.pdf",
            "news_date": "2022-08-13 17:02:47",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of the Company for the first Quarter ended 30th June, 2022.",
            "news_id": "fa8c0186-8f19-4c80-8d41-6a9d22525816",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb94dc59-02b8-4655-85aa-60b0c0c02062.pdf",
            "news_date": "2022-08-13 17:01:02",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The First Quarter Ended 30Th June, 2022",
            "news_body": "Financial Results for the first quarter ended 30th June, 2022",
            "news_id": "90c90e48-1b8d-4ec7-aa54-8e97045507bf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a0f26f6-8ea9-4f56-ab48-2a60dfbfc9fe.pdf",
            "news_date": "2022-08-13 13:30:35",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for  Board Meeting Held On 13-Aug-2022 To Consider Financial Statements For The Period Ended June 2022 And Other Business Matters",
            "news_body": "SMS Pharmaceuticals Limited  has informed the Exchange about Board Meeting held on 13-Aug-2022 to consider financial statements for the period ended June 2022 and Other business matters",
            "news_id": "2c6936e7-978d-4986-aed4-cdc9b9abd3db",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80884c9b-8c94-49a7-834b-c4b3712bef38.pdf",
            "news_date": "2022-08-13 13:26:26",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2022",
            "news_body": "Disclosure of Related Party Transactions for the half year ended 31st March, 2022",
            "news_id": "314f87a1-c1e0-447b-929e-0ecf854e55e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d362000c-27a5-47a6-9c41-06383c6204d9.pdf",
            "news_date": "2022-06-07 15:47:58",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q4 & FY 2022 Financial Results",
            "news_id": "050f46ad-5bf4-4a1d-83e9-ecee5f4375e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22aa3315-e4ac-401f-a31b-664b15ced7d2.pdf",
            "news_date": "2022-06-02 15:33:37",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Correction In The Notes To Financial Results Submitted For The Quarter And Year Ended 31St March, 2022",
            "news_body": "Correction in the Notes to Financial Results submitted for the Quarter and Year ended 31st March, 2022<BR>",
            "news_id": "6d69d895-d122-4fa4-879c-d0a494d1d0cf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89861129-f703-47cd-99b7-cbbbf78e946a.pdf",
            "news_date": "2022-05-30 19:14:56",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May, 2022",
            "news_body": "Outcome of Board Meeting held on 30th May, 2022<BR>",
            "news_id": "59109131-3c3d-4b4a-8114-ee562c79c880",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d9c430d-93ad-4939-bdb1-ef5a87d22f1b.pdf",
            "news_date": "2022-05-30 14:07:06",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 9Th February, 2022",
            "news_body": "With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held today, inter-alia considered and approved the following:<BR> <BR> 1. The Standalone and Consolidated Un-audited Financial Results for the third Quarter and Nine months ended 31st December, 2021 along with the Limited Review Report.<BR> <BR>",
            "news_id": "04337def-9bf8-4955-8537-b39c0f2895b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1eded5b5-8af1-4067-bf5b-0d66b213cbba.pdf",
            "news_date": "2022-02-09 13:02:40",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a herewith a copy of investor presentation of the Company.<BR> This Investor Presentation may also be accessed on the website of the Company at www.smspharma.com<BR>",
            "news_id": "522f2d84-d869-4f8a-98ca-cb9c77677f7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68201631-9d90-47c6-b677-097d3c4373de.pdf",
            "news_date": "2021-11-13 14:13:09",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 12Th November, 2021",
            "news_body": "With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held today, inter-alia considered and approved the following:<BR> <BR> 1. The Standalone and Consolidated Un-audited Financial Results for the Quarter and half year ended 30th September, 2021 along with the Limited Review Report.<BR> <BR> 2. Approved the resignation of Mr. V S Venkatish, Company Secretary and Compliance Officer, and he will be relieved on or before 31st January, 2022.<BR>",
            "news_id": "5d8bef2a-9f8b-4c4d-b89e-e10e234b9d69",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1ad2b33-736d-446c-b0ee-cb1e33f65095.pdf",
            "news_date": "2021-11-12 14:02:19",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a herewith a copy of investor presentation of the Company.",
            "news_id": "a7bf08fa-453a-4c29-955d-4b9c3d40afb9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f713eb0-e46c-421e-8cf9-f3a57d577612.pdf",
            "news_date": "2021-10-28 17:23:18",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 7Th August, 2021 - Revised",
            "news_body": "With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held on today, inter-alia considered and approved the following:<BR> <BR> 1. Approved the Standalone and Consolidated Un-audited Financial Results for the Quarter ended 30th June, 2021 along with the Limited Review Report<BR> 2. Reclassification of promoter group shareholding from promoter category to public category.<BR> 3. Directors Report by the Board for the FY 2020-21<BR> 4. Convening the 33rd Annual General Meeting on 30th, September, 2021 <BR> 5. Dividend Distribution Policy<BR>",
            "news_id": "e86fb101-c8bc-4c6f-a5fa-eb739ce79935",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78ea5a82-a738-425f-827a-3032cc7cc47c.pdf",
            "news_date": "2021-08-07 14:38:53",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th August, 2021",
            "news_body": "With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held on today, inter-alia considered and approved the following:<BR> <BR> 1. Approved the Standalone and Consolidated Un-audited Financial Results for the Quarter ended 30th June, 2021 along with the Limited Review Report<BR> 2. Reclassification of promoter group shareholding from promoter category to public category.<BR> 3. Directors Report by the Board for the FY 2020-21<BR> 4. Convening the 33rd Annual General Meeting on 30th, September, 2021 <BR> 5. Dividend Distribution Policy<BR>",
            "news_id": "b666bf11-d801-4fea-879b-218fbad46a49",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c3669d9-1853-4f00-b534-8ef72747890d.pdf",
            "news_date": "2021-08-07 13:06:43",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SMSPHARMA",
            "disp": "SMS Pharmaceuticals",
            "bse_code": 532815,
            "isin": "INE812G01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board meeting held on 28th May, 2021.",
            "news_id": "91711557-6bec-4b6d-9682-0bae19e98fc1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39b8263d-8241-412a-84f0-dae3be3a56ea.pdf",
            "news_date": "2021-05-28 17:12:31",
            "seo": "sms-pharmaceuticals-ltd",
            "ltp": 318.95,
            "ch": 0.44999999999998863,
            "pch": 0.14128728414442343,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 14329,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}